Recurrent Adult Soft Tissue Sarcoma Completed Phase 1 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00720174Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaTreatment
NCT00098579Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By SurgeryTreatment